Dawn Kelly-Sullivan
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Neurotransmitter Receptor Influence on Behavior, Renal Transplantation Outcomes and Treatments, Regulation of Appetite and Obesity, Pancreatic function and diabetes
Most-Cited Works
- → Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice(2003)181 cited
- → RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORING(1995)60 cited
- → Identification of a PCSK9-LDLR disruptor peptide with in vivo function(2021)44 cited
- → New bicyclic cannabinoid receptor-1 (CB1-R) antagonists(2005)42 cited
- → Design of a Potent CB1Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents(2012)39 cited
- → Site for Unpurified Islet Transplantation is an Important Parameter for Determination of the Outcome of Graft Survival and Function(1995)35 cited
- → Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor(2013)27 cited
- → Pharmacological characterization of a small molecule inhibitor of c-Jun kinase(2008)23 cited
- → In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity(2010)23 cited